Children and COVID-19: State Data Report | Duration of SARS-CoV-2 Natural Immunity and Protection against the Delta Variant: A Retrospective Cohort Study | Quarantine and Isolation | Frequently Asked Questions on the Emergency Use Authorization for Paxlovid for Treatment of COVID-19
• Outpatient COVID-19 Management Strategies in Children and Adolescents
• SARS-CoV-2-specific memory B cells can persist in the elderly who have lost detectable neutralising antibodies
• Science Brief: SARS-CoV-2 Infection-induced and Vaccine-induced Immunity
• Azithromycin in patients with COVID-19: a systematic review and meta-analysis
• Effect of High-Flow Oxygen Therapy vs Conventional Oxygen Therapy on Invasive Mechanical Ventilation and Clinical Recovery in Patients With Severe COVID-19
• In non–critically ill patients with COVID-19, therapeutic anticoagulation improved survival to discharge without organ support
• Africa’s COVID-19 numbers surge, but hospital cases stay low
• B.1.1.529 escapes the majority of SARS-CoV-2 neutralizing antibodies of diverse epitopes
• mRNA booster immunization elicits potent neutralizing serum activity against the SARS-CoV-2 Omicron variant
• Protection against Covid-19 by BNT162b2 Booster across Age Groups
• SARS-CoV-2 vaccine protection and deaths among US veterans
• New phase 3 analyses show that a single dose of REGEN-CoV (Casirivimab and Imdevimab) provides long-term protection against COVID-19
• Pfizer’s novel COVID-19 oral antiviral treatment candidate reduced risk of hospitalization or death
• WHO estimate: 115,000 health workers have died from Covid-19, as calls for vaccine access grow
• Virologic features of SARS-CoV-2 infection in children
• COVID-19 Vaccination and Non–COVID-19 Mortality Risk
• Association of Statins and 28-Day Mortality in Patients Hospitalized with SARS CoV-2 Infection
• Assessment of Cognitive Function in Patients After COVID-19 Infection
• Covid-19 Breakthrough Infections in Vaccinated Health Care Workers
• Coronavirus (COVID-19) Update: FDA Takes Additional Actions on the Use of a Booster Dose for COVID-19 Vaccines
• FACT SHEET FOR HEALTH CARE PROVIDERS: EMERGENCY USE AUTHORIZATION (EUA) OF REGEN-COV
• Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: the TOGETHER randomised, platform clinical trial
• Routine Vaccination Coverage — Worldwide, 2020 Antibody Testing Is Not Currently Recommended to Assess Immunity After COVID-19 Vaccination: FDA Safety Communication
• The Flawed Science of Antibody Testing for SARS-CoV-2 Immunity
Effect of Antithrombotic Therapy on Clinical Outcomes in Outpatients With Clinically Stable Symptomatic COVID-19 | Comprehensive antibody profiling of mRNA vaccination in children | Heterologous SARS-CoV-2 Booster Vaccinations – Preliminary Report | WHO, UN set out steps to meet world COVID vaccination targets
The durability of immunity against reinfection by SARS-CoV-2: a comparative evolutionary study | IVIG Compared to IVIG Plus Infliximab in Multisystem Inflammatory Syndrome in Children | AZD7442 request for Emergency Use Authorization for COVID-19 prophylaxis filed in US | COVID-19 Outbreaks at Youth Summer Camps — Louisiana, June–July 2021
Incidence, co-occurrence, and evolution of long-COVID features: A 6-month retrospective cohort study of 273,618 survivors of COVID-19 | Safety Monitoring of an Additional Dose of COVID-19 Vaccine — United States, August 12–September 19, 2021 | Impact of Timing of Tocilizumab Use in Hospitalized Patients With SARS-CoV-2 Infection
Virologic features of SARS-CoV-2 infection in children | Steroids use in non-oxygen requiring COVID-19 patients: a systematic review and meta-analysis | NIH builds large nationwide study population of tens of thousands to support research on long-term effects of COVID-19
The COVID-19 Hospitalization Metric in the Pre- and Post-vaccination Eras as a Measure of Pandemic Severity: A Retrospective, Nationwide Cohort Study | High genetic barrier to escape from human polyclonal SARS-CoV-2 neutralizing antibodies | Considerations in boosting COVID-19 vaccine immune responses | HHS Announces State/territory-coordinated Distribution System for Monoclonal Antibody Therapeutics | Daily testing for contacts of individuals with SARS-CoV-2 infection and attendance and SARS-CoV-2 transmission in English secondary schools and colleges: an open-label, cluster-randomised trial | SARS-CoV-2 Transmission to Masked and Unmasked Close Contacts of University Students with COVID-19 — St. Louis, Missouri, January–May 2021 | A year of genomic surveillance reveals how the SARS-CoV-2 pandemic unfolded in Africa
Long-Term Symptoms Among Adults Tested for SARS-CoV-2 — United States, January 2020–April 2021 | Overlooked Shortcomings of Observational Studies of Interventions in Coronavirus Disease 2019: An Illustrated Review for the Clinician | Long-Term Symptoms Among Adults Tested for SARS-CoV-2
Ivermectin Intended for Animals: Letter to Stakeholders – Do Not Use in Humans as a Treatment for COVID-19 | Characteristics and Outcomes of Women With COVID-19 Giving Birth at US Academic Centers During the COVID-19 Pandemic | Children and COVID-19: State-Level Data Report | Long COVID – the physical and mental health of children and non-hospitalised young people 3 months after SARS-CoV-2 infection; a national matched cohort study (The CLoCk) Study. | Outbreak Associated with SARS-CoV-2 B.1.617.2 (Delta) Variant in an Elementary School — Marin County, California, May–June 2021 | 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study | Convalescent plasma recommendations from IDSA
A comprehensive educational resource on all aspects of parasitic diseases and their impact on humanity around the globe.
Help bring the latest medical and basic biological information pertaining to diseases caused by eukaryotic parasites to every practicing physician and medical student within the United States.
English 
Spanish